EUVIMEDEUVIMED entdecken
Multizentrische StudieValidierungsstudie

FUO-PETMamba: a pet maximum-intensity-projection-based artificial intelligence framework for aetiological classification of fever of unknown origin with multicentre validation

Chong Jiang, Zekun Jiang, Yue Teng, Ruihe Lai, Yi Zhou, Zitong Zhang, Hexiao Huang, Yunyi Liu, Zhichao Xie, Ming Jiang, Jingyan Xu, Chongyang Ding und 2 weitere

European Journal of Nuclear Medicine and Molecular Imaging · 2026

DOI: 10.1007/s00259-026-08061-4 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2026. Verfasst von Chong Jiang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: Fever of Unknown Origin, Artificial Intelligence, Positron Emission Tomography Computed Tomography, Image Processing, Computer-Assisted. Die Arbeit nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Fever of unknown origin (FUO) remains diagnostically challenging because of heterogeneous causes, non-specific clinical manifestations, and overlapping imaging findings. We developed and validated FUO-PETMamba, a PET maximum-intensity-projection (MIP)-based artificial intelligence framework for AI-assisted aetiological classification of FUO. METHODS: This retrospective multicentre study included 681 patients with FUO who underwent baseline [18 F]FDG PET/CT, comprising one development cohort (n = 355) and two independent external validation cohorts (n = 195 and n = 131). FUO-PETMamba is a weakly supervised framework analysing PET MIP images generated from PET data. Model performance was assessed by discrimination, calibration, decision curve analysis (DCA). Attention-based visual explanations were generated using attention mechanisms and gradient-based activation mapping. A reader study assessed the potential assistive effect of model-predicted probabilities on physicians with different PET/CT experience. RESULTS: In the development cohort, FUO-PETMamba achieved AUCs of 0.838 for malignancy, 0.851 for infection, 0.914 for autoimmune disease, and 0.788 for miscellaneous causes. Corresponding AUCs were 0.809, 0.815, 0.805, and 0.849 in external validation cohort 1, and 0.808, 0.772, 0.701, and 0.927 in external validation cohort 2, respectively. Calibration and decision curve analysis suggested potential clinical benefit for the major aetiological categories, although performance varied across cohorts and classes. The miscellaneous category should be interpreted cautiously because of limited case numbers and low positive predictive value and F1 scores. In the reader study, AI assistance improved diagnostic accuracy for junior and intermediate physicians, whereas changes in senior-physician performance were variable. Post hoc attention-based visualisations highlighted clinically plausible hypermetabolic patterns and served as qualitative explanatory aids. CONCLUSIONS: FUO-PETMamba provides a PET MIP-based AI-assisted diagnostic support framework for aetiological classification of FUO across multicentre cohorts and may help reduce experience-dependent diagnostic variability after prospective validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fever of Unknown OriginArtificial IntelligencePositron Emission Tomography Computed TomographyImage Processing, Computer-AssistedHumansFemaleRetrospective StudiesMaleMiddle AgedFluorodeoxyglucose F18AdultAgedReproducibility of Results

Stichwörter der Autor:innen

PET maximum-intensity projection[18F]FDG PET/CTaetiological classificationartificial intelligenceattention-based visual explanationfever of unknown originhuman-AI collaboration

Substanzen

Fluorodeoxyglucose F18

Autor:innen und Institutionen

  • Department of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • West China Biomedical Big Data Center, West China Hospital, Sichuan University, Chengdu, China.
  • Department of Nuclear Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
  • Department of Oncology, West China Hospital of Sichuan University, Chengdu, China.
  • Department of Hematology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, No. 321, Zhongshan Road, Nanjing, Jiangsu, 210008, China. xjy1967@sina.com.
  • Department of Nuclear Medicine, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, No. 321, Zhongshan Road, Nanjing, Jiangsu Province, 210008, China. chongyangding@163.com.

ORCID-Profile: Rong Tian

Zitieren

APA

Jiang, C., Jiang, Z., Teng, Y., Lai, R., Zhou, Y., Zhang, Z., Huang, H., Liu, Y., Xie, Z., Jiang, M., Xu, J., Ding, C., Qu, L., & Tian, R. (2026). FUO-PETMamba: a pet maximum-intensity-projection-based artificial intelligence framework for aetiological classification of fever of unknown origin with multicentre validation. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-026-08061-4

Vancouver

Jiang C, Jiang Z, Teng Y, Lai R, Zhou Y, Zhang Z, et al. FUO-PETMamba: a pet maximum-intensity-projection-based artificial intelligence framework for aetiological classification of fever of unknown origin with multicentre validation. European Journal of Nuclear Medicine and Molecular Imaging. 2026. doi:10.1007/s00259-026-08061-4

BibTeX
@article{Jiang2026,
  author = {Jiang, Chong and Jiang, Zekun and Teng, Yue and Lai, Ruihe and Zhou, Yi and Zhang, Zitong and Huang, Hexiao and Liu, Yunyi and Xie, Zhichao and Jiang, Ming and Xu, Jingyan and Ding, Chongyang and Qu, Linhao and Tian, Rong},
  title = {FUO-PETMamba: a pet maximum-intensity-projection-based artificial intelligence framework for aetiological classification of fever of unknown origin with multicentre validation},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2026},
  doi = {10.1007/s00259-026-08061-4}
}
Kostenlos starten →